Cenix Prepares to Establish Belgian Subsidiary
January 13, 2011
Cenix Prepares to Establish Belgian Subsidiary
The new unit is part of "a major growth and diversification initiative ongoing since 2008 to broaden the company's range of activities beyond [its core] cell-based RNAi services," Dresden, Germany-based Cenix said.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Germany's Cenix Establishes US Subsidiary to Expand R&D Capabilities
March 1, 2012 / Gene Silencing News - Cenix Partners with US Non-Profit on Rare Disease Research
September 27, 2012 / Gene Silencing News - Cenix Inks Research Deal with Sygnis
November 17, 2011 / Gene Silencing News - Gradalis Releases New Clinical Data on Cancer Vaccine
May 16, 2013 / Gene Silencing News - Former Traversa Exec Forms New Company to Develop Oligo-modification Tech
May 16, 2013 / Gene Silencing News